Cm Management, LLC Selecta Biosciences Inc Transaction History

Cm Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.62 - $0.85 $244,601 - $335,340	-394,518 Reduced 56.36%	305,482 $256,000
Q2 2023 Aug 04, 2023	BUY	$1.04 - $1.4 $104,000 - $140,000	100,000 Added 16.67%	700,000 $784,000
Q2 2022 Aug 08, 2022	BUY	$0.67 - $1.4 $67,000 - $140,000	100,000 Added 20.0%	600,000 $786,000
Q1 2022 May 09, 2022	BUY	$1.23 - $3.31 $123,000 - $331,000	100,000 Added 25.0%	500,000 $615,000
Q1 2021 May 12, 2021	BUY	$2.92 - $5.07 $219,000 - $380,250	75,000 Added 23.08%	400,000 $1.81 Million
Q4 2020 Feb 04, 2021	BUY	$1.64 - $3.42 $533,000 - $1.11 Million	325,000 New	325,000 $985,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.